LATARCIBART
UNII 3JL79KZX47

Substance Identification & Data

This profile provides standardized clinical and technical data for Latarcibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3JL79KZX47.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3036400-21-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3JL79KZX47

CAS Registry Number

3036400-21-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LATARCIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C224752

National Cancer Institute reference terminology for clinical and research data.

INN ID

13690

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Latarcibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LATARCIBART

Common Names & Synonyms

H-GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-443) (VH (HOMO SAPIENS IGHV4-4*02 (90.8%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT (9.7.9) (26-34.52-58.97-105)) (1-116) -HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, 12-G4V5 H P10, 6-G4V3 CH2 E1.2, 9-G4V24 CH3 L107, S114 (CH1 (117-214), HINGE 1-12 S10>P (224) (215-226), CH2 L1.2>E (231), L92 (305) (227-336), CH3 M107>L (424), N114>S (430) (337-441), CHS (442-443)) (117-443)), (130-213')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS (1'-213') (V-KAPPA (HOMO SAPIENS IGKV3-15*01 (96.8%) -IGKJ5*01 (100%), CDR-IMGT (6.3.8) (27'-32'.50'-52'.89'-96')) (1'-106') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (152'), V101 (190')) (107'-213')); DIMER (222-222'':225-225'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G4 (224-PROLINE,231-GLUTAMIC ACID,424-LEUCINE,430-SERINE), ANTI-(HUMAN VITAMIN K-DEPENDENT ANTICOAGULANT PROTEIN S) (HUMAN MONOCLONAL VGA039 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VGA039 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PROS1 (PROTEIN S, VITAMIN K-DEPENDENT PROTEIN S)), HOMO SAPIENS MONOCLONAL ANTIBODY (LATARCIBART)

LATARCIBART [INN]